Timothy R. Morgan

29.0k total citations · 4 hit papers
207 papers, 12.4k citations indexed

About

Timothy R. Morgan is a scholar working on Epidemiology, Hepatology and Pathology and Forensic Medicine. According to data from OpenAlex, Timothy R. Morgan has authored 207 papers receiving a total of 12.4k indexed citations (citations by other indexed papers that have themselves been cited), including 149 papers in Epidemiology, 132 papers in Hepatology and 47 papers in Pathology and Forensic Medicine. Recurrent topics in Timothy R. Morgan's work include Liver Disease Diagnosis and Treatment (138 papers), Hepatitis C virus research (80 papers) and Liver Disease and Transplantation (63 papers). Timothy R. Morgan is often cited by papers focused on Liver Disease Diagnosis and Treatment (138 papers), Hepatitis C virus research (80 papers) and Liver Disease and Transplantation (63 papers). Timothy R. Morgan collaborates with scholars based in United States, France and United Kingdom. Timothy R. Morgan's co-authors include Marc G. Ghany, Herbert L. Bonkovsky, Adrian M. Di Bisceglie, Jules L. Dienstag, M. Mazen Jamal, William M. Lee, Anna S. Lok, Philippe Mathurin, Gregory T. Everson and Karen L. Lindsay and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and Annals of Internal Medicine.

In The Last Decade

Timothy R. Morgan

196 papers receiving 12.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Alcoholic Hepatitis

2009 640 citations Timothy R. Morgan et al. profile →
The Natural History of Hepatitis C Virus (HCV) Infection

2006 617 citations Timothy R. Morgan et al. profile →
Hepatitis C Guidance 2019 Update: American Association for the Study of Liver Diseases–Infectious Diseases Society of America Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection

2019 569 citations Marc G. Ghany, Timothy R. Morgan et al. Hepatology profile →
Resmetirom therapy for metabolic dysfunction-associated steatotic liver disease: October 2024 updates to AASLD Practice Guidance

2024 69 citations Vincent Chen, Timothy R. Morgan et al. Hepatology profile →

Peers

Countries citing papers authored by Timothy R. Morgan

Since Specialization

Citations

This map shows the geographic impact of Timothy R. Morgan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timothy R. Morgan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timothy R. Morgan more than expected).

Fields of papers citing papers by Timothy R. Morgan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Timothy R. Morgan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timothy R. Morgan. The network helps show where Timothy R. Morgan may publish in the future.

Co-authorship network of co-authors of Timothy R. Morgan

This figure shows the co-authorship network connecting the top 25 collaborators of Timothy R. Morgan. A scholar is included among the top collaborators of Timothy R. Morgan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Timothy R. Morgan. Timothy R. Morgan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Defining Risk in Alcohol-Associated Liver Disease Using the Model for End-Stage Liver Disease 2025 ·The American Journal of Gastroenterology ·Richard Parker, Guruprasad P. Aithal, Michael Allison, Mayur Brahmania, Ewan Forrest, Hannes Hagström, Brian T. Lee, (unknown), Anne McCune, Timothy R. Morgan, (unknown), Steven Masson, Neil Rajoriya, Devanshi Seth, Ken Liu, (unknown), Esperance Schaefer, Jay Luther, Russell P. Goodman, Ian Rowe, (unknown)	0
2	Clinical and genetic risk factors for progressive fibrosis in metabolic dysfunction–associated steatotic liver disease 2024 ·Hepatology Communications ·David E. Kaplan, Craig C. Teerlink, Tae‐Hwi Schwantes‐An, Trina M. Norden‐Krichmar, Scott L. DuVall, Timothy R. Morgan, Philip S. Tsao, Benjamin F. Voight, Julie A. Lynch, Marijana Vujković, Kyong‐Mi Chang	5
3	Resmetirom therapy for metabolic dysfunction-associated steatotic liver disease: October 2024 updates to AASLD Practice Guidance breakdown → 2024 ·Hepatology ·Vincent Chen, Timothy R. Morgan, Yaron Rotman, Heather Patton, Kenneth Cusi, Fasiha Kanwal, W. Ray Kim	69
4	Betaine for the prevention and treatment of insulin resistance and fatty liver in a high-fat dietary model of insulin resistance in C57BL mice 2024 ·Frontiers in Nutrition ·Elango Kathirvel, Kengathevy Morgan, Olga Malysheva, Marie A. Caudill, Timothy R. Morgan	6
5	Access to Evaluation for Liver Transplantation in the Veterans Health Administration 2024 ·Digestive Diseases and Sciences ·Vera Yakovchenko, Michael F. Chang, Rubén Hernáez, Joseph Awad, (unknown), (unknown), Heather McCurdy, (unknown), (unknown), (unknown), Mark Wilson, Jason A. Dominitz, Heather Patton, (unknown), Timothy R. Morgan, Shari S. Rogal	0
6	One ALT Is Not Like the Other 2023 ·Gastroenterology ·Christine M. Hunt, Tae Hoon Lee, Timothy R. Morgan, Sheldon Campbell	10
7	Integrated Transcriptomic and Proteomic Analysis Identifies Plasma Biomarkers of Hepatocellular Failure in Alcohol-Associated Hepatitis 2022 ·American Journal Of Pathology ·Josepmaria Argemí, (unknown), Marina Gritsenko, Ana Clemente, (unknown), José M. Herranz, Zhang‐Xu Liu, Stephen R. Atkinson, Richard Smith, Trina M. Norden‐Krichmar, (unknown), Andrew Stolz, John A. Tayek, Ramón Bataller, Timothy R. Morgan, Jon Jacobs	8
8	Core implementation strategies for improving cirrhosis care in the Veterans Health Administration 2022 ·Hepatology ·Vera Yakovchenko, Timothy R. Morgan, Edward J. Miech, (unknown), (unknown), Sandra P. Gibson, (unknown), Heather McCurdy, (unknown), Rachel Gonzalez, (unknown), Byron J. Powell, Jasmohan S. Bajaj, Jason A. Dominitz, Maggie Chartier, David B. Ross, Matthew Chinman, Shari S. Rogal	12
9	A Phase IIa Trial of Metformin for Colorectal Cancer Risk Reduction among Individuals with History of Colorectal Adenomas and Elevated Body Mass Index 2019 ·Cancer Prevention Research ·Jason A. Zell, Christine E. McLaren, Timothy R. Morgan, Michael J. Lawson, Sherif Rezk, Gregory Albers, Wen‐Pin Chen, Joseph C. Carmichael, (unknown), Ellen Richmond, Luz M. Rodriguez, Éva Szabó, Leslie G. Ford, Michaël Pollak, Frank L. Meyskens	23
10	Treatment of Severe Alcoholic Hepatitis 2016 ·Gastroenterology ·Mark Thursz, Timothy R. Morgan	47
11	A Phase IIa Randomized, Double-Blind Trial of Erlotinib in Inhibiting Epidermal Growth Factor Receptor Signaling in Aberrant Crypt Foci of the Colorectum 2015 ·Cancer Prevention Research ·Daniel L. Gillen, Frank L. Meyskens, Timothy R. Morgan, Jason A. Zell, Robert E. Carroll, Richard V. Benya, Wen‐Pin Chen, Allen Mo, Chris Tucker, Asmita Bhattacharya, Zhiliang Huang, (unknown), Vanessa Wong, (unknown), Rachel Gonzalez, Luz M. Rodriguez, Éva Szabó, Daniel W. Rosenberg, Steven M. Lipkin	2
12	A Phase II Randomized, Controlled Trial of S-Adenosylmethionine in Reducing Serum α-Fetoprotein in Patients with Hepatitis C Cirrhosis and Elevated AFP 2015 ·Cancer Prevention Research ·Timothy R. Morgan, Kathryn Osann, Teodoro Bottiglieri, Neville R. Pimstone, John C. Hoefs, Ke-Qin Hu, Tarek Hassanein, Thomas Boyer, (unknown), Wen‐Pin Chen, Ellen Richmond, Rachel Gonzalez, Luz M. Rodriguez, Frank L. Meyskens	15
13	Sofosbuvir With Velpatasvir in Treatment-Naive Noncirrhotic Patients With Genotype 1 to 6 Hepatitis C Virus Infection 2015 ·Annals of Internal Medicine ·Gregory T. Everson, William Towner, Mitchell Davis, David Wyles, Ronald Nahass, Paul J. Thuluvath, K. Peter Etzkorn, Federico Hinestrosa, Myron J. Tong, Mordechai Rabinovitz, John McNally, Diana M. Brainard, Lingling Han, Brian Doehle, John G. McHutchison, Timothy R. Morgan, Raymond T. Chung, Tram T. Tran	4
14	The inflammasome in alcoholic hepatitis: Its relationship with Mallory–Denk body formation 2014 ·Experimental and Molecular Pathology ·Yue Peng, Barbara A. French, Brittany Tillman, Timothy R. Morgan, Samuel W. French	40
15	Cytotoxic T cell immunity against the non-immunogenic, murine, hepatocellular carcinoma Hepa1-6 is directed towards the novel alternative form of macrophage colony stimulating factor 2009 ·Cellular Immunology ·Lisheng Ge, Jian Gang Zhang, (unknown), Christina Delgado, (unknown), Qinghong Dan, Neil Hoa, Tuong-Vi Nguyen, (unknown), Jimmy Tam Huy Pham, Ramón L. Sánchez, H. Terry Wepsic, Timothy R. Morgan, Martin R. Jadus	5
16	Incidence of Hepatocellular Carcinoma and Associated Risk Factors in Hepatitis C-Related Advanced Liver Disease 2008 ·Gastroenterology ·Anna S. Lok, Leonard B. Seeff, Timothy R. Morgan, Adrian M. Di Bisceglie, Richard K. Sterling, Teresa M. Curto, Gregory T. Everson, Karen L. Lindsay, William M. Lee, Herbert L. Bonkovsky, Jules L. Dienstag, Marc G. Ghany, Chihiro Morishima, Zachary Goodman	452
17	Management of alcoholic hepatitis 2003 ·Drug and Therapeutics Bulletin ·Timothy R. Morgan	7
18	Clinical pathway effects on treatment of the alcohol withdrawal syndrome. 1996 ·PubMed ·Timothy R. Morgan, Lial Kofoed, (unknown)	6
19	Cell-mediated hepatic injury in alcoholic liver disease 1993 ·Gastroenterology ·Antonio Chedid, (unknown), (unknown), Samuel W. French, (unknown), Timothy R. Morgan, Gary A. Roselle, Bernard A. Nemchausky, Carlo H. Tamburro, Eugene R. Schiff, Craig J. McClain, Luis Marsano, John I. Allen, Arun Samanta, Robert E. Weesner, William G. Henderson	90
20	Calcitonin Gene-Related Peptide in Hepatorenal Syndrome. A Possible Mediator of Peripheral Vasodilation? 1992 ·Journal of Clinical Gastroenterology ·Sanjeev Gupta, Timothy R. Morgan, Gilbert S. Gordan	29

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact